Gallbladder Diseases: Clinical Trials

25 trials for Gallbladder Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

25 completed. 25 Phase 3, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 325Completed 25
Phase 26Completed 6

Follow Gallbladder Diseases: new trials by email Literature Review of Gallbladder Diseases trials Research Report on Gallbladder Diseases

Trials (filtered) newest first · largest first

All 25 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Role of Intra-Operative Aspiration in Distended GB in LC
Laparoscopic needle - Acute Calculous Cholecystitis, Gallbladder Empyema
Phase 3CompletedAswan University702023-07-012026-01-30
Naldebain for Pain Management of Laparoscopic Cholecystectomy
Dinalbuphine sebacate, Placebo solution - Pain, Postoperative, Pain, Chronic
Phase 2 / Phase 3CompletedE-DA Hospital802021-08-302022-04-20
Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)-China Extension Study
Pembrolizumab, Gemcitabine, Cisplatin - Biliary Tract Carcinoma
Phase 3CompletedMerck Sharp & Dohme LLC1582020-07-102026-04-15
Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)
Pembrolizumab, Gemcitabine, Cisplatin - Biliary Tract Carcinoma
Phase 3CompletedMerck Sharp & Dohme LLC10692019-09-242026-03-24
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers
Cisplatin, Gemcitabine Hydrochloride, Nab-paclitaxel - Stage III Distal Bile Duct Cancer AJCC v8, Stage III Gallbladder Cancer AJCC v8
Phase 3CompletedSWOG Cancer Research Network4522019-02-072026-01-12
Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
Varlitinib, Capecitabine, Placebo (for Varlitinib) - Biliary Tract Cancer
Phase 2 / Phase 3CompletedASLAN Pharmaceuticals1512017-07-042021-08-03
Digital SpyGlass Confirmed Common Bile Duct Stones Clearance Without Fluoroscopy
Endoscopic Retrograde Cholangioscopy by SpyGlass (ERCS) - Common Bile Duct Diseases, Stone - Biliary
Phase 3CompletedChulalongkorn University512015-12-012016-11-18
A Randomized Controlled Trial on EGBD vs PC for Acute Cholecystitis.
EUS-guided gallbladder drainage (EGBD), Percutaneous cholecystostomy (PC) - Acute Cholecystitis
Phase 2 / Phase 3CompletedChinese University of Hong Kong602014-08-012019-07-30
Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers
Active Symptom Control, L-folinic acid, 5 FU - Biliary Tract Cancer, Gallbladder Cancer
Phase 3CompletedThe Christie NHS Foundation Trust1622014-02-012020-01-28
Renalof in the Treatment of Elderly Patients With Gallstones
Renalof, Placebo - Cholelithiasis
Phase 3CompletedCatalysis SL402010-01-012012-05-08
New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma
Somatostatin, epirubicin, cisplatin, LV(Leucovorin)、 5-FU(5-Fluorouracil) - Gallbladder Neoplasms
Phase 3CompletedShanghai Jiao Tong University School of Medicine2162009-10-012013-12-20
Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery
gemcitabine hydrochloride, oxaliplatin, clinical observation - Extrahepatic Bile Duct Cancer, Gallbladder Cancer
Phase 3CompletedUNICANCER1902009-07-012017-01-25
Piperacllin Versus Placebo in Patients Undergoing Surgery for Acute Cholecystitis
Piperacillin-tazobactam combination product, Saline solution - Cholecystitis, Acute
Phase 3CompletedKarolinska Institutet1002009-03-012018-03-06
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Fentanyl sublingual spray, Placebo - Cancer
Phase 3CompletedINSYS Therapeutics Inc1302007-10-012014-03-05
Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery
porfimer sodium, biliary stenting - Extrahepatic Bile Duct Cancer, Gallbladder Cancer
Phase 3CompletedUniversity College, London922007-07-012013-02-20
Acute Cholecystitis - Early Laparoscopic Surgery Versus Antibiotic Therapy and Delayed Elective Cholecystectomy
moxifloxacin, cholecystectomy - Acute Cholecystitis
Phase 3CompletedHeidelberg University6442006-10-012012-07-23
Small-incision Open Cholecystectomy or Laparoscopic Cholecystectomy for Gallbladder Disease
Laparoscopic cholecystectomy, Small-incision open cholecystectomy - Biliary Tract Diseases, Gallbladder Diseases
Phase 2 / Phase 3CompletedUmeå University3552006-09-012015-04-24
Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer
capecitabine, clinical observation, adjuvant therapy - Extrahepatic Bile Duct Cancer, Gallbladder Cancer
Phase 3CompletedUniversity Hospital Southampton NHS Foundation Trust3602006-03-012013-08-26
Palliative Biliary Stenting on the Quality of Life of Patients With Unresectable Carcinoma Gallbladder With Hiliar Block.
Biliary stenting - Gallbladder Cancer
Phase 2 / Phase 3CompletedAll India Institute of Medical Sciences602006-01-012013-07-11
Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery
cisplatin, gemcitabine hydrochloride, oxaliplatin - Extrahepatic Bile Duct Cancer, Gallbladder Cancer
Phase 2 / Phase 3CompletedFederation Francophone de Cancerologie Digestive342005-10-012016-05-30

Showing 20 of 25. Sign in to see all of them.

Narrower conditions

Gallbladder Neoplasms (14)  ·  Bile Duct Neoplasms (10)  ·  Cholecystitis (5)  ·  Cholangiocarcinoma (4)  ·  Cholecystitis, Acute (4)  ·  Gallstones (4)  ·  Carcinoma, Hepatocellular (3)  ·  Liver Neoplasms (3)  ·  Neoplasms (3)  ·  Appendiceal Neoplasms (2)  ·  Appendicitis (2)  ·  Bacterial Infections and Mycoses (2)  ·  Biliary Tract Neoplasms (2)  ·  Carcinoma, Ovarian Epithelial (2)  ·  Cholecystolithiasis (2)

Broader conditions

Digestive System Diseases (25)  ·  Biliary Tract Diseases (24)  ·  Digestive System Neoplasms (14)  ·  Neoplasms by Site (14)  ·  Biliary Tract Neoplasms (12)  ·  Bile Duct Diseases (11)  ·  Neoplasms (11)  ·  Adenocarcinoma (7)  ·  Carcinoma (7)  ·  Neoplasms by Histologic Type (7)  ·  Neoplasms, Glandular and Epithelial (7)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Liver Diseases (5)  ·  Calculi (4)

Interventions

Cisplatin (6)  ·  Gemcitabine (6)  ·  Oxaliplatin (3)  ·  Capecitabine (2)  ·  Chemotherapy, Adjuvant (2)  ·  Doripenem (2)  ·  Watchful Waiting (2)  ·  pembrolizumab (2)  ·  1,2-diaminocyclohexaneplatinum II citrate (1)  ·  130-nm albumin-bound paclitaxel (1)  ·  ARRY-334543 (1)  ·  Albumin-Bound Paclitaxel (1)  ·  Cholecystectomy (1)  ·  Cholecystectomy, Laparoscopic (1)  ·  Dexamethasone (1)

Sponsors

Chinese University of Hong Kong (2)  ·  Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2)  ·  Merck Sharp & Dohme LLC (2)  ·  University College, London (2)  ·  ASLAN Pharmaceuticals (1)  ·  All India Institute of Medical Sciences (1)  ·  Aswan University (1)  ·  Catalysis SL (1)  ·  Chulalongkorn University (1)  ·  E-DA Hospital (1)  ·  Federation Francophone de Cancerologie Digestive (1)  ·  Heidelberg University (1)  ·  INSYS Therapeutics Inc (1)  ·  Karolinska Institutet (1)  ·  NCIC Clinical Trials Group (1)

Countries

China (6)  ·  United Kingdom (5)  ·  United States (4)  ·  France (3)  ·  Japan (3)  ·  Spain (3)  ·  Taiwan (3)  ·  Australia (2)  ·  Canada (2)  ·  Germany (2)  ·  Hong Kong (2)  ·  South Korea (2)  ·  Sweden (2)  ·  Argentina (1)  ·  Belgium (1)

Top investigators

Ali H Abdelaal (1)  ·  Bruno Chauffert (1)  ·  Clive Stubbs (1)  ·  Eveline Boucher, MD (1)  ·  Folke Hammarqvist, Ass Prof (1)  ·  Frances KY Cheung, MBChB (1)  ·  John A. Bridgewater (1)  ·  Juan Valle, Prof (1)  ·  Larry Dillaha, MD (1)  ·  Markus W Buechler, Prof. (1)

Results publications

PMID 19670912, PMID 20211892, PMID 38661512, PMID 42176183, PMID 16849762, PMID 17916243, PMID 20375404, PMID 22480131, PMID 23085096, PMID 23640665, PMID 24022431, PMID 25241229, PMID 27020837, PMID 28388942, PMID 32165407, PMID 32860109, PMID 33798493, PMID 37075781, PMID 39206260, PMID 39671534, PMID 40154623, PMID 40268484, PMID 41887529

NIH funding

2019 (1), 2023 (1), U10CA180888 (1)